Verify Brand granted US patent for 'Authentication and Tracking System'

Verify Brand announces it has received a United States patent (No. US 7,752,137 B2) for an "Authentication and Tracking System."

"We are very pleased with this development and, while a patent was over 6 years in the making, it affirms our long-standing commitment to and leadership in the field of serialization-based solutions for Digital Authentication, Track and Trace(R) across government and manufacturer supply chains," said Kevin Erdman, President of Verify Brand. "We are continuing our patent strategy with currently outstanding applications in the U.S. and abroad."

Verify Brand is a widely known and respected innovation leader in the emerging and fast-growing field of authenticating, tracking and tracing "serialized" end products, their components, assets and security documents using hosted Web-based software applications and related data that is created, accessed and managed in a secure and central repository. Government entities from revenue authorities to customs agents and manufacturers are expanding their traditional security materials strategy by adopting authentication and "track and trace" solutions based on secure serialization. This accelerating activity is driven by expanding government regulations, world and national health organizations, standards organizations and the related increased emphasis on consumer safety, crime reduction and prevention, brand value protection, revenue maximization, supply chain efficiency and other factors. The acknowledged fact is that product counterfeiting and other unauthorized activities are now a global, still growing and painful epidemic with multiple and drastically negative effects on consumers, manufacturers, suppliers and governments.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.